Anti-snoring Treatment Market - By Device (Mandible Advancement Devices, Tongue Stabilizing Devices, Nasal Devices, Continuous Positive Airway Pressure Devices, Chin Straps), By Distribution Channel (Hospitals, Clinics, Retail Pharmacies, E-commerce) & Forecast, 2023-2032

Industry Statistics

Anti-snoring Treatment Market size was worth USD 1 billion in 2022 and is projected to expand at an 8% CAGR from 2023-2032. Rising prevalence of sleeping disorders will accelerate industry growth.
 

To get more details on this report: Request Free Sample PDF
 

Increasing incidences of sleeping disorders are expected to proliferate the need for anti-snoring treatment solutions. As per data published by the National Heart, Lung, & Blood Institute (NHLBI) in March 2022, between 50 million to 70 million people in the U.S. suffer from sleep disorders. Insomnia and sleeping disorders are major health concerns hampering the overall quality of life. Snoring is one of the key indications of potential health problems such as sleep apnea, certain cardiovascular diseases, and breath obstruction.

High-performance anti-snoring devices and treatments tend to be expensive, which may limit product penetration across low- and middle-income countries. Continuous positive airway pressure devices (CPAP) are conventionally used to minimize snoring. However, these devices can be costly with the highest pricing reaching USD 3,500. Moreover, these devices are often excluded from insurance policies, compelling patients to spend money out of their own pockets, affecting the adoption rate across the patient population.  
 

Growing prevalence of OSA will fuel the demand for CPAP devices

To get more details on this report: Request Free Sample PDF
 

Anti-snoring treatment market from continuous positive airway pressure (CPAP) devices is expected to record over 7.5% CAGR through 2023-2032. The growing demand for CPAP devices can be attributed to the increasing use in the treatment of snoring, and obstructive sleep apnea (OSA). CPAP therapy is very effective in keeping the user’s airway open thus ensuring a continuous stream of air with the help of a mask. OSA is one of the most common sleep-related disorders, affecting a large portion of the global population.
 

Preference for OTC devices will boost online sales of anti-snoring solutions

To get more details on this report: Request Free Sample PDF
 

Anti-snoring treatment market valuation from the E-Commerce Distribution Channel is estimated to reach USD 925 million by 2032. The growing customer inclination toward over-the-counter (OTC) products due to availability, and affordability will propel the demand for anti-snoring devices across online channels. The rise in the number of e-pharmacies and online drug stores is enhancing patient access to treatments that do not require a prescription.
 

E-commerce also offers easy access and favorable pricing to buyers in middle-income countries. Furthermore, extensive developments in the field of internet infrastructure and robust cyber connectivity across rural areas are fueling the use of e-commerce channels for sourcing medical products, including anti-snoring treatments.
 

Supportive government initiatives to aid North America industry landscape

North America anti-snoring treatment market size is poised to surpass USD 1 billion by 2032. North America is home to a massive healthcare sector with hefty private and public investments, supportive government initiatives, increasing spending, and growing awareness regarding sleep disorders. The grant aims to boost education and awareness associated with OSA in the U.S. Similar private-public initiatives and funding will complement the expansion of the anti-snoring treatment industry in North America.
 

Anti-Snoring Treatment Market Players

Some of the key companies in the global anti-snoring treatment industry include Apnea Science, SomnoMed, Koninklijke Philips, Airway Management Inc, Tomed GmBH, Meditas, GlaxoSmithKline Plc, Fisher & Paykel Healthcare, ResMed, Theravent (Foundation Consumer Healthcare), The Pure Sleep Co (Sleep Science Partners, Inc), Vyaire Medical.
 

Recent Developments:

• May 2023 - Illusion Aligners introduced an innovative easy-to-wear, comfortable, and effective oral anti-snoring device offering users an enhanced sleep experience.
• December 2022 - Mindray announced the launch of its wearable patient monitoring device, the mWear system, designed to track vital signs and ensure efficient patient care and workflow.
   

The anti-snoring treatment market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By device

• Mandible advancement devices
• Tongue stabilizing devices
• Nasal devices
• Continuous positive airway pressure devices
• Chin straps
• Others

By distribution channel

• Hospitals
• Clinics
• Retail pharmacies
• E-commerce
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Poland
  • Switzerland
  • Netherlands
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel